Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants
JAMA Network Open
•
June 05, 2026
Maternal RSV vaccination reduces infant hospitalizations
Maternal respiratory syncytial virus prefusion F vaccination was linked to about two-thirds fewer infant hospitalizations for respiratory syncytial virus in the first 90 days of life. *Retrospective test-negative case-control study; Level 3b (OCEBM).
- Level of evidence
- Level 3b (OCEBM)
- DocG quality score
- 7.3 / 10
Read the full summary free
Patients, intervention, outcomes, results, and clinical applicability in about 300 words — plus new summaries in your inbox 3× per week.
Sign in with Google
